{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:44:33Z","timestamp":1786578273204,"version":"build-2736575974"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T00:00:00Z","timestamp":1586044800000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003761","name":"Universitair Medisch Centrum Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaip.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T13:25:59Z","timestamp":1535549159000},"page":"1317-1318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Which opioids in case of mast cell activation disorders?"],"prefix":"10.1016","volume":"7","author":[{"given":"Marion","family":"Lepelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Pralong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Boccon","family":"Gibod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.08.011_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000542-198502000-00005","article-title":"Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone","volume":"62","author":"Hermens","year":"1985","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2018.08.011_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1213\/01.ANE.0000097168.32472.0D","article-title":"Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in\u00a0vivo microdialysis study in human skin","volume":"98","author":"Blunk","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00000542-199211000-00016","article-title":"Human basophil\/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release","volume":"77","author":"Stellato","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02074699","article-title":"Anaphylactoid reactions and histamine release do not occur after application of the opioid tramadol","volume":"20","author":"Barth","year":"1987","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaip.2018.08.011_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jaip.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2885.2007.00911.x","article-title":"Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs","volume":"30","author":"Guedes","year":"2007","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jaip.2018.08.011_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0885-3924(98)00115-8","article-title":"Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride","volume":"17","author":"Katcher","year":"1999","journal-title":"J\u00a0Pain Symptom Manage"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818305452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818305452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:18:15Z","timestamp":1761974295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818305452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2213219818305452"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.08.011","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which opioids in case of mast cell activation disorders?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}